Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers
- PMID: 37729043
- PMCID: PMC10545069
- DOI: 10.1097/LGT.0000000000000763
Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers
Abstract
Objectives: Sexual gender minority (SGM) populations are at risk for human papillomavirus (HPV)-related cancers of the anogenital tract and oropharynx and often face barriers to health care. The goals of this document are to clarify language to provide inclusive care for SGM populations and to provide recommendations for screening and prevention of HPV-related cancers in SGM populations.
Materials and methods: An expert committee convened by the American Society for Colposcopy and Cervical Pathology performed a narrative review of the literature through February 2023. A comprehensive MEDLINE database search was performed for relevant studies. The literature review was divided into categories by organ/topic and by SGM population. Given the variability in available data for several of the categories, recommendations were made based on national guidelines where appropriate or expert opinion where there were less data to support risk-based guidelines.
Results: Definitions and terminology relevant to SGM populations are presented. The authors advocate the adoption of sexual orientation gender identity data collection and an organ-based screening approach, which is possible with knowledge of patient anatomy, sexual behaviors, and clinical history. This includes screening for cervical cancer per national recommendations, as well as screening for anal, vulvar, vaginal, penile, and oral cancers based on risk factors and shared clinical decision making. The authors recommend consideration of HPV vaccination in all SGM individuals up to age 45 years old who are at risk.
Conclusions: An organ-based screening approach is part of a global strategy to create an inclusive care environment and mitigate barriers to screening and prevention of HPV-mediated cancers in SGM populations.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP.
Conflict of interest statement
The authors have declared they have no conflicts of interest.
Figures

Comment in
-
Commentary on New Guidance for Human Papillomavirus-Related Cancer Screening Among Sexual and Gender Minority Populations.J Low Genit Tract Dis. 2023 Oct 1;27(4):322-323. doi: 10.1097/LGT.0000000000000764. J Low Genit Tract Dis. 2023. PMID: 37729044 No abstract available.
Similar articles
-
Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center.J Community Health. 2018 Aug;43(4):792-801. doi: 10.1007/s10900-018-0486-0. J Community Health. 2018. PMID: 29480339 Free PMC article.
-
Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.Vaccine. 2018 Jun 18;36(26):3868-3875. doi: 10.1016/j.vaccine.2018.02.043. Epub 2018 May 16. Vaccine. 2018. PMID: 29778516 Free PMC article.
-
Acceptability of Anal Human Papillomavirus Home Self-Sampling and Clinician Sampling Among Sexual and Gender Minority Individuals in Milwaukee, Wisconsin: The Prevent Anal Cancer Self-Swab Study.LGBT Health. 2024 Jan;11(1):47-56. doi: 10.1089/lgbt.2023.0012. Epub 2023 Oct 24. LGBT Health. 2024. PMID: 37870947 Free PMC article. Clinical Trial.
-
Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.J Low Genit Tract Dis. 2025 Apr 1;29(2):168-179. doi: 10.1097/LGT.0000000000000866. Epub 2025 Jan 13. J Low Genit Tract Dis. 2025. PMID: 39804372 Free PMC article. Review.
-
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468. J Low Genit Tract Dis. 2019. PMID: 30907775
Cited by
-
High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.Open Forum Infect Dis. 2024 Nov 12;11(12):ofae662. doi: 10.1093/ofid/ofae662. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39679352 Free PMC article.
-
Strategies to Optimize Cervical Cancer Screening Rates Among Transgender and Gender-Diverse People Assigned Female at Birth.J Gen Intern Med. 2024 Dec;39(16):3333-3338. doi: 10.1007/s11606-024-09026-9. Epub 2024 Sep 23. J Gen Intern Med. 2024. PMID: 39313668
-
Advancing equity in cervical cancer screening for sexual and gender minoritized people assigned female at birth (SGM AFAB) in the United States: recommendations from healthcare equity leaders.Reprod Health. 2025 Jul 29;22(1):135. doi: 10.1186/s12978-025-02082-2. Reprod Health. 2025. PMID: 40731350 Free PMC article.
-
Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study.EClinicalMedicine. 2025 Jan 13;80:103037. doi: 10.1016/j.eclinm.2024.103037. eCollection 2025 Feb. EClinicalMedicine. 2025. PMID: 40135165 Free PMC article.
References
-
- Simelela PN. WHO global strategy to eliminate cervical cancer as a public health problem: an opportunity to make it a disease of the past. Int J Gynaecol Obstet 2021;152:1–3. - PubMed
-
- Institute of Medicine Committee on Lesbian, G.B, et al. . The National Academies Collection: Reports funded by National Institutes of Health, in The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington (DC): National Academies Press (US), National Academy of Sciences; 2011. - PubMed
-
- Eliseo J, Pérez-Stable MD, NIMHD director statement in support of diverse and inclusive speaking panels. June 21, 2019. Available at: https://www.nimhd.nih.gov/about/directors-corner/messages/message_06-21-.... Accessed May 30, 2023.